Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa.

Kishnani, P.S., Rush, E.T., Arundel, P. et al. (10 more authors) (2017) Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Molecular Genetics and Metabolism, 122 (1-2). pp. 4-17. ISSN 1096-7192

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/BY/4.0/)
Keywords: Alkaline phosphatase; Asfotase alfa; Enzyme replacement therapy; Hypophosphatasia; Metabolic bone diseases; Therapeutic drug monitoring; Tissue-nonspecific alkaline phosphatase
Dates:
  • Accepted: 24 July 2017
  • Published (online): 25 July 2017
  • Published: September 2017
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 29 Sep 2017 11:30
Last Modified: 29 Sep 2017 11:30
Published Version: https://doi.org/10.1016/j.ymgme.2017.07.010
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.ymgme.2017.07.010
Related URLs:

Share / Export

Statistics